New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
Objective: Neurological complications such as chemotherapy-induced peripheral neuropathy (CIPN) and neuropathic pain are frequent side effects of neurotoxic chemotherapy agents. An increasing survival rate and frequent administration of adjuvant chemotherapy treatments involving neurotoxic agents ma...
Main Authors: | Janet Schloss, Maree Colosimo, Luis Vitetta |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | Asia-Pacific Journal of Oncology Nursing |
Subjects: | |
Online Access: | http://www.apjon.org/article.asp?issn=2347-5625;year=2016;volume=3;issue=1;spage=73;epage=85;aulast=Schloss |
Similar Items
-
Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
by: Rozalyn L. Rodwin, et al.
Published: (2022-03-01) -
Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine
by: David Balayssac, et al.
Published: (2023-12-01) -
The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01) -
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01) -
Exploring Outcome Priorities and Real-Life Management of Chemotherapy-Induced Peripheral Neurotoxicity: A Survey of the Italian Association for the Study of Pain members
by: Sardo S, et al.
Published: (2023-09-01)